Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-26

FDA Approved: SUFENTANIL CITRATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved Hospira's supplemental application for sufentanil citrate, finalizing an additional regulatory action for this generic opioid analgesic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUFENTANIL CITRATE (SUFENTANIL CITRATE)

Snippet

SUPPL AP for SUFENTANIL CITRATE (SUFENTANIL CITRATE)